当前位置: 首页 > 详情页

Takayasu Arteritis with Dyslipidemia Increases Risk of Aneurysm

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [2]Capital Med Univ, Beijing Anzhen Hosp, Dept Pathol, Beijing, Peoples R China; [3]Capital Med Univ, Beijing Anzhen Hosp, Dept Intervent Radiol, Beijing, Peoples R China; [4]Tufts Med Ctr, Pulm & Crit Care Div, Boston, MA 02111 USA; [5]Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [6]Capital Med Univ, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ,Beijing Collaborat Innovat Ctr Cardio, Beijing, Peoples R China
出处:
ISSN:

摘要:
Low-density lipoprotein cholesterol (LDL-C) has been associated with the occurrence of abdominal aortic aneurysm. However, whether LDL-C elevation associated with aneurysms in large vessel vasculitis is unknown. The aim of this study is to investigate the clinical and laboratory features of Takayasu arteritis (TAK) and explore the risk factors that associated with aneurysm in these patients. This retrospective study compared the clinical manifestations, laboratory parameters, and imaging results of 103 TAK patients with or without aneurysms and analyzed the risk factors of aneurysm formation. 20.4% of TAK patients were found to have aneurysms. The LDL-C levels was higher in the aneurysm group than in the non-aneurysm group (2.9 +/- 0.9 mmol/l vs. 2.4 +/- 0.9 mmol/l, p = 0.032). Elevated serum LDL-C levels increased the risk of aneurysm by 5.8-fold (p = 0.021, odds ratio [OR] = 5.767, 95% confidence interval [CI]: 1.302-25.543), and the cutoff value of level of serum LDL-C was 3.08 mmol/l. The risk of aneurysm was 4.2-fold higher in patients with disease duration >5 years (p = 0.042, OR = 4.237, 95% CI: 1.055-17.023), and 2.9-fold higher when an elevated erythrocyte sedimentation rate was present (p = 0.077, OR = 2.851, 95% CI: 0.891-9.115). In this study, elevated LDL-C levels increased the risk of developing aneurysms in patients with TAK.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
最新[2023]版:
大类 | 2 区 综合性期刊
小类 | 2 区 综合性期刊
JCR分区:
出版当年[2017]版:
Q1 MULTIDISCIPLINARY SCIENCES
最新[2023]版:
Q1 MULTIDISCIPLINARY SCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [5]Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [6]Capital Med Univ, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ,Beijing Collaborat Innovat Ctr Cardio, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院